A detailed history of Highview Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Highview Capital Management LLC holds 5,133 shares of ABBV stock, worth $908,284. This represents 0.42% of its overall portfolio holdings.

Number of Shares
5,133
Previous 4,916 4.41%
Holding current value
$908,284
Previous $843,000 20.17%
% of portfolio
0.42%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $35,553 - $43,254
217 Added 4.41%
5,133 $1.01 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $24,766 - $28,921
-160 Reduced 3.15%
4,916 $843,000
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $811,246 - $924,339
5,076 New
5,076 $924,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Highview Capital Management LLC Portfolio

Follow Highview Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highview Capital Management LLC with notifications on news.